As part of its research, Ambiotis announces promising results on a model of IBD and intestinal irritation to evaluate pro-resolving compounds.  The model presents a specific metabolipidomic signature that contains immunoresolvent molecules. 

This model will thus represent a tool of choice to test compounds that act on intestinal permeability and inflammation and that aim to restore a good intestinal balance thanks to the mobilization of resolutive pathways.

More Informations

Contact us

+33 (0)5 62 24 41 57

+33 (0)5 61 25 64 02

Send an e-mail via the form

Canal Biotech 2 - 3 Rue des satellites 31400 Toulouse - France

Receive our news

Recent news

Ambiotis - www.ambiotis.com - Copyright © 2017 - All rights reserved - Legal Notice